SCHEMBL17488779

SCHEMBL17488779

Cc1nc2c(F)cc(-c3nc(Nc4ccc(CN5CCNC[C@H]5C)cn4)ncc3F)cc2n1C(C)C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 20/20 0.71
CDK6 Q00534 18/20 0.71
CDK1 P06493 14/20 0.71
CDK2 P24941 13/20 0.71
CCND3 P30281 7/20 0.71
CCNA2 P20248 6/20 0.71
CDK7 P50613 6/20 0.71
CDK9 P50750 6/20 0.71
CCNB1 P14635 4/20 0.71
CCNE1 P24864 4/20 0.71
CDK5 Q00535 3/20 0.71
CIT O14578 1/20 0.71
GAK O14976 1/20 0.71
DYRK3 O43781 1/20 0.71
CCNT1 O60563 1/20 0.71
STK16 O75716 1/20 0.71
CCNK O75909 1/20 0.71
STK10 O94804 1/20 0.71
PRKD3 O94806 1/20 0.71
ABCB11 O95342 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17488962 1.00 CDK4 (0.71) CDK4CDK6CDK1CDK2CCND3
SCHEMBL17488738 0.92 CDK4 (0.68) CDK4CDK6CDK1CDK2CCND3
SCHEMBL17489158 0.92 CDK4 (0.68) CDK4CDK6CDK1CDK2CCND3
SCHEMBL17489257 0.90 CDK6 (0.57) CDK4CDK6CDK1CDK2CCND3
SCHEMBL30459468 0.89 CDK4 (0.84) CDK4CDK6CDK1CDK2CCND3
SCHEMBL30460094 0.89 CDK4 (0.84) CDK4CDK6CDK1CDK2CCND3
SCHEMBL2490067 0.89 CDK4 (0.84) CDK4CDK6CDK1CDK2CCND3
SCHEMBL17488723 0.87 CDK4 (0.61) CDK4CDK6CDK1CDK2CCND3
SCHEMBL17489157 0.87 CDK4 (0.61) CDK4CDK6CDK1CDK2CCND3
SCHEMBL17489255 0.87 CDK4 (0.73) CDK4CDK6CDK1CDK2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016015605-A1 COMPOUNDS AS CDK SMALL-MOLECULE INHIBITORS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-02-04 WO disclosed